GLP-1 Receptor Agonists: Metabolic Effects and Their Role in Managing T2DM

Target Audience
The intended audience for this educational initiative is primary care providers, including internal medicine and family medicine physicians, nurse practitioners, and physician assistants, who are front-line clinicians in managing patients with type 2 diabetes.

Program Overview
This activity will inform clinicians about the pleiotropic effects of GLP-1 RAs, the demonstrated clinical efficacy of these agents for managing patients with T2DM and a variety of comorbid conditions, and guideline recommendations for incorporating GLP-1 RAs into management strategies for T2DM.

Learning Objectives
Upon completion of this activity, participants should be able to:

Describe the pleiotropic mechanism of action of GLP-1 receptor agonists.
Discuss efficacy and safety data for approved GLP-1 receptor agonists, including efficacy for glycemic and extra-glycemic effects.
Incorporate GLP-1 receptor agonists into evidence-based individualized management plans for patients with type 2 diabetes aligned with current guideline recommendations.